Verastem, Inc.
VSTM· Nasdaq
Released Aug 6, 2026, after the close
10-Q filed Aug 6, 2026, 37 days after period end · 0001104659-26-092007
| Metric | Q2 2026 | Q2 2025 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $40.08M | $2.14M | $500.00K | $4.31M |
| Net Income | -$34.67M | -$25.93M | -$16.90M | -$23.01M |
| EPS Diluted |
Verastem, Inc. · CIK 1526119 · Engraved from SEC EDGAR
| -$0.35 |
| -$0.62 |
| -$0.10 |
| -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.